For the treatment of impetigo. Controlled studies in pregnant women show no evidence of fetal risk. For the treatment of lower respiratory tract infections due to S pneumoniae, H influenzae including ampicillin-resistant strainsKlebsiella species, Staphylococcus aureus penicillinase- and non-penicillinase-producing strainsS pyogenes, and Escherichia coli.
Recommended for surgical prophylaxis for the following procedures: Aminoglycosides should be avoided in patients with chronic kidney disease when possible. Diluted solutions are stable for 24 hours at room temperature and for 7 days under refrigeration. Lengthening the dosing interval has been associated with a lower risk of toxicities but a higher risk of subtherapeutic drug concentrations, especially toward the end of the dosing interval.
For serious skin and skin structure infections. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. Published guidelines suggest methods for maintenance dosing adjustments: Deep IM injection into large muscle mass; aspirate before injecting to avoid inadvertent injection into a blood vessel.
Rare potential complications in the nursing infant include alterations of gut flora that might result in diarrhea or related complications e. Print this page Add to My Med List.
Inject directly into vein over minutes or slowly into tubing of free-flowing compatible IV solution. Read the full article.
Related Drug Information Drug Summary. The serum half-life after IV injection is approximately 80 minutes. For the treatment of tonsillitis.
It was concluded that the antibiotics ampicillin, ciprofloxacin, clarithromycin, doxycycline, metronidazole, ofloxacin, roxithromycin, temafloxacin, and tetracycline did not alter plasma concentrations of OCs.
Usual Adult Dose for Bacterial Infection
Do not use in pregnancy. To inspect the drug powder for foreign matter or discoloration, peel the foil strip from the drug chamber. Because the risk of serious reactions is relatively rare, the use of many cephalosporins is considered compatible with breast feeding. A single additional usual dose should be administered at the end of each dialysis. Dilution For IV infusion, further dilute in compatible solution i. For life-threatening infections or infections due to less susceptible organisms, 1.